Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry.
J Mass Spectrom Adv Clin Lab
; 25: 53-60, 2022 Aug.
Article
em En
| MEDLINE
| ID: mdl-35910410
EMA, European Medicines Agency; IDA, Information dependent acqusition; IgG1, immunoglobulin G1; LC-MS/MS; LC-MS/MS, Liquid chromatography-tandem mass spectrometry; MS, Multiple sclerosis; MWCO, molecular weight cut-off; Multiple sclerosis; OVERLORD-MS, Ocrelizumab vErsus Rituximab Off-Label at the Onset of Relapsing MS; Ocrelizumab; QTOF, quadrupole time-of-flight; QTRAP, quadrupole ion trap; ROS-MS, Rituximab and Ocrelizumab in Serum with Multiple Sclerosis study; TDM, therapeutic drug monitoring; Therapeutic drug monitoring; Therapeutic monoclonal antibodies; UHPLC, ultra high performance liquid chromatography; t-mAb, therapeutic monoclonal antibody
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article